rs181892888
Variant summary
Our verdict is Pathogenic. The variant received 10 ACMG points: 10P and 0B. PVS1PM2
The NM_021098.3(CACNA1H):c.2030C>A(p.Ser677*) variant causes a stop gained change. The variant allele was found at a frequency of 0.00000141 in 1,418,566 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Synonymous variant affecting the same amino acid position (i.e. S677S) has been classified as Benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_021098.3 stop_gained
Scores
Clinical Significance
Conservation
Publications
- hyperaldosteronism, familial, type IVInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- childhood absence epilepsyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, childhood absence, susceptibility to, 6Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 10 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1H | ENST00000348261.11 | c.2030C>A | p.Ser677* | stop_gained | Exon 10 of 35 | 1 | NM_021098.3 | ENSP00000334198.7 | ||
CACNA1H | ENST00000569107.6 | c.2030C>A | p.Ser677* | stop_gained | Exon 10 of 34 | 1 | ENSP00000454990.2 | |||
CACNA1H | ENST00000711493.1 | c.2030C>A | p.Ser677* | stop_gained | Exon 10 of 34 | ENSP00000518778.1 | ||||
CACNA1H | ENST00000565831.7 | c.2030C>A | p.Ser677* | stop_gained | Exon 10 of 34 | 1 | ENSP00000455840.1 | |||
CACNA1H | ENST00000711450.1 | c.2030C>A | p.Ser677* | stop_gained | Exon 10 of 35 | ENSP00000518762.1 | ||||
CACNA1H | ENST00000564231.6 | c.2030C>A | p.Ser677* | stop_gained | Exon 10 of 35 | 1 | ENSP00000457555.2 | |||
CACNA1H | ENST00000638323.1 | c.1991C>A | p.Ser664* | stop_gained | Exon 10 of 35 | 5 | ENSP00000492267.1 | |||
CACNA1H | ENST00000562079.6 | c.2030C>A | p.Ser677* | stop_gained | Exon 10 of 34 | 1 | ENSP00000454581.2 | |||
CACNA1H | ENST00000711438.1 | c.1991C>A | p.Ser664* | stop_gained | Exon 10 of 34 | ENSP00000518754.1 | ||||
CACNA1H | ENST00000711482.1 | c.2030C>A | p.Ser677* | stop_gained | Exon 10 of 36 | ENSP00000518771.1 | ||||
CACNA1H | ENST00000711485.1 | c.2030C>A | p.Ser677* | stop_gained | Exon 10 of 35 | ENSP00000518774.1 | ||||
CACNA1H | ENST00000711455.1 | c.2030C>A | p.Ser677* | stop_gained | Exon 10 of 36 | ENSP00000518768.1 | ||||
CACNA1H | ENST00000711483.1 | c.2030C>A | p.Ser677* | stop_gained | Exon 10 of 35 | ENSP00000518772.1 | ||||
CACNA1H | ENST00000711456.1 | c.2030C>A | p.Ser677* | stop_gained | Exon 10 of 34 | ENSP00000518769.1 | ||||
CACNA1H | ENST00000621827.2 | n.2030C>A | non_coding_transcript_exon_variant | Exon 10 of 37 | 6 | ENSP00000518766.1 | ||||
CACNA1H | ENST00000637236.3 | n.2030C>A | non_coding_transcript_exon_variant | Exon 10 of 34 | 5 | ENSP00000492650.2 | ||||
CACNA1H | ENST00000639478.1 | n.2030C>A | non_coding_transcript_exon_variant | Exon 10 of 35 | 5 | ENSP00000491945.1 | ||||
CACNA1H | ENST00000640028.1 | n.1413C>A | non_coding_transcript_exon_variant | Exon 10 of 35 | 5 | ENSP00000491488.1 | ||||
CACNA1H | ENST00000711442.1 | n.*1477C>A | non_coding_transcript_exon_variant | Exon 9 of 34 | ENSP00000518758.1 | |||||
CACNA1H | ENST00000711448.1 | n.2030C>A | non_coding_transcript_exon_variant | Exon 10 of 36 | ENSP00000518760.1 | |||||
CACNA1H | ENST00000711449.1 | n.2030C>A | non_coding_transcript_exon_variant | Exon 10 of 35 | ENSP00000518761.1 | |||||
CACNA1H | ENST00000711451.1 | n.2030C>A | non_coding_transcript_exon_variant | Exon 10 of 36 | ENSP00000518763.1 | |||||
CACNA1H | ENST00000711452.1 | n.2030C>A | non_coding_transcript_exon_variant | Exon 10 of 36 | ENSP00000518764.1 | |||||
CACNA1H | ENST00000711453.1 | n.2030C>A | non_coding_transcript_exon_variant | Exon 10 of 36 | ENSP00000518765.1 | |||||
CACNA1H | ENST00000711484.1 | n.2030C>A | non_coding_transcript_exon_variant | Exon 10 of 35 | ENSP00000518773.1 | |||||
CACNA1H | ENST00000711486.1 | n.2030C>A | non_coding_transcript_exon_variant | Exon 10 of 37 | ENSP00000518775.1 | |||||
CACNA1H | ENST00000711487.1 | n.2030C>A | non_coding_transcript_exon_variant | Exon 10 of 36 | ENSP00000518776.1 | |||||
CACNA1H | ENST00000711488.1 | n.2030C>A | non_coding_transcript_exon_variant | Exon 10 of 35 | ENSP00000518777.1 | |||||
CACNA1H | ENST00000711442.1 | n.*1477C>A | 3_prime_UTR_variant | Exon 9 of 34 | ENSP00000518758.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000141 AC: 2AN: 1418566Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 701814 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome Cov.: 33
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at